Take your read length, and multiply it by the number of bases to get the total bases present in your dataset. So for a 1M SE @ 50bp, you have 50Mb. For 1M PE @50bpx50bp, you have 100Mb. If you look at one PE file (reads1), then you get 50Mb. Note, that the bfast file will contain both PE in the same file, so that would be 100Mb.
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
Originally posted by nilshomer View PostTake your read length, and multiply it by the number of bases to get the total bases present in your dataset. So for a 1M SE @ 50bp, you have 50Mb. For 1M PE @50bpx50bp, you have 100Mb. If you look at one PE file (reads1), then you get 50Mb. Note, that the bfast file will contain both PE in the same file, so that would be 100Mb.
The formula i'm using for N is
N = (Genome size x Coverage) / ( RL1 + RL2)
So if my Genome size is 100Mb, Coverage is 10 and RL1 = RL2 = 50 (PE)
N = 100,000,000 x 10 / 100 = 10,000,000 read pairs
i.e *_10X_PE_1.fq = *_10x_PE_2.fq = 10,000,000 reads.
Now, if RL2=0, keeping coverage and genome size the same,
N = 100,000,000 x 10 / 50 = 20,000,000 read pairs or reads
i.e *_10X_SE_.fq1 = 20,000,000 reads and *_10X_SE_2.fq = 0 reads.
I Hope i'm right till here.
Furthermore, if i have already generated 20X coverage PE for the same genome,
N = 100,000,000 x 20 / 100 = 20,000,000 read pairs
i.e *_20X_PE_1.fq = *_20X_PE_2.fq = 20,000,000 reads.
Is it safe to assume that
either *_20X_PE_1.fq OR *_20X_PE_2.fq can be used as a substitute for *_10X_SE_.fq1 as both have the same number of reads?
Comment
Latest Articles
Collapse
-
by seqadmin
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...-
Channel: Articles
04-04-2024, 04:25 PM -
-
by seqadmin
Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...-
Channel: Articles
03-22-2024, 06:39 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 04-11-2024, 12:08 PM
|
0 responses
30 views
0 likes
|
Last Post
by seqadmin
04-11-2024, 12:08 PM
|
||
Started by seqadmin, 04-10-2024, 10:19 PM
|
0 responses
32 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 10:19 PM
|
||
Started by seqadmin, 04-10-2024, 09:21 AM
|
0 responses
28 views
0 likes
|
Last Post
by seqadmin
04-10-2024, 09:21 AM
|
||
Started by seqadmin, 04-04-2024, 09:00 AM
|
0 responses
52 views
0 likes
|
Last Post
by seqadmin
04-04-2024, 09:00 AM
|
Comment